All the data collected suggest that FC2 represents the first candidate capable of inducing cancer cell death by interaction with type I BIR domains, proving to be an optimizable hit-to-lead molecule for the development of a new class of compounds able to tune NF-κB and BIR1 activities within pro-survival macromolecular complexes. Here, NFKB1 is linked to cancer.